Brainstorm Cell Therapeutics (BCLI) EBITDA (2002 - 2026)
Brainstorm Cell Therapeutics (BCLI) EBITDA from Mar 31, 2002 to Mar 31, 2026. The TTM Brainstorm Cell Therapeutics (BCLI) EBITDA is -$8.73M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Brainstorm Cell Therapeutics (BCLI) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -27.79% |
| 3 Years TTM | -28.82% |
| 5 Years TTM | -21.92% |
| 10 Years TTM | +0.88% |
| All Time TTM | +25.16% |
Annual EBITDA change of Brainstorm Cell Therapeutics (BCLI)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$2.01M | -79.38% |
| 2025 | -$9.75M | -14.85% |
| 2024 | -$11M | -45.91% |
| 2023 | -$21M | -13.73% |
| 2022 | -$25M | +1.07% |
| 2021 | -$24M | -22.82% |
| 2020 | -$31M | +37.74% |
| 2019 | -$23M | +63.73% |
| 2018 | -$14M | +184.11% |
| 2017 | -$4.91M | -2.00% |
| 2016 | -$5.01M | -40.71% |
| 2015 | -$8.45M | +15.60% |
| 2014 | -$7.31M | +52.29% |
| 2013 | -$4.80M | +46.79% |
| 2012 | -$3.27M | -13.03% |
| 2011 | -$3.76M | +67.11% |
| 2010 | -$2.25M | +26.40% |
| 2009 | -$1.78M | -48.70% |
| 2008 | -$3.47M | -44.39% |
| 2007 | -$6.24M | +87.95% |
| 2006 | -$3.32M | +4642.86% |
| 2004 | -$70K | +40.00% |
| 2003 | -$50K | +66.67% |
| 2002 | -$30K | N/A |
Comparison Brainstorm Cell Therapeutics (BCLI) five years EBITDA CAGR with competitors
Brainstorm Cell Therapeutics (BCLI) five years EBITDA CAGR is -21.92%.